The trademark application XLP was filed by Kite Pharma, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 19, 2020, and it was registered by office on July 27, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on January 14, 2024.
Goods And Services
The mark was filed in class 40 with following description of goods:
Custom manufacturing of biological tissue, blood, and cell cultures for medical purposes
Custom manufacturing of pharmaceutical preparations for immunotherapy, including T cell therapy
Custom manufacturing of biological preparations for the treatment of cancer.